Pulmonx CORP Form 4 insider transactions
NASDAQ
LUNG
Pulmonx CORPRose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock at $8.71 per share on May 22, 2024, according to a Form 4 filing.
NASDAQ
LUNG
Pulmonx CORPChief Financial Officer of Pulmonx Corp, Mehul Joshi, reports the acquisition of restricted stock units and stock options.
NASDAQ
LUNG
Pulmonx CORPChief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, sold 1,184 shares of common stock at $7.49 per share on April 22, 2024, according to a Form 4 filing.
NASDAQ
LUNG
Pulmonx CORPRose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock at a price of $9.36 per share on March 22, 2024, according to a Form 4 filing with the SEC.
NASDAQ
LUNG
Pulmonx CORPSteven S. Williamson, CEO of Pulmonx Corp, reports the acquisition of restricted stock units and stock options.
NASDAQ
LUNG
Pulmonx CORP4/A: Pulmonx Corp Executive Rose Geoffrey Beran Amends SEC Filing to Correct Stock Option and RSU Details
An amended SEC filing reveals corrections to the number of shares underlying employee stock options and restricted stock units (RSUs) previously reported by Pulmonx Corp's Chief Commercial Officer, Rose Geoffrey Beran.
NASDAQ
LUNG
Pulmonx CORPJohn McKune, Interim CFO of Pulmonx Corp, files an amendment to a previous Form 4 to correct typographical errors related to the number of shares underlying employee stock options and restricted stock units (RSUs).
NASDAQ
LUNG
Pulmonx CORPDavid Aaron Lehman, General Counsel of Pulmonx Corp, files an amendment to a previous SEC Form 4 to correct errors in the reported number of shares related to employee stock options and restricted stock units.
NASDAQ
LUNG
Pulmonx CORPChief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, reports the sale of common stock to cover tax obligations and the acquisition of restricted stock units and stock options.
NASDAQ
LUNG
Pulmonx CORPInterim CFO of Pulmonx Corp, John McKune, reports the acquisition and disposal of common stock and stock options.
NASDAQ
LUNG
Pulmonx CORPGeneral Counsel David Aaron Lehman of Pulmonx Corp reports the sale of common stock to cover tax obligations and the acquisition of restricted stock units and stock options.
NASDAQ
LUNG
Pulmonx CORPPulmonx Corp CEO Glendon E. French III sold shares of common stock on March 1, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.